Inventor · disambiguated record
Scott Hansen
Also filed as: HANSEN SCOTT · HANSEN SCOTT G
19 granted patents·9 pending applications·111 citations·filing 2004–2023
94Inventor score
Files withUNIV OREGON HEALTH & SCIENCE24AERAS1INT AIDS VACCINE INITIATIVE INC1INT AIDS VACCINE INITITATIVE INC1SCIENCE UNIVERSITY OREGON HEALTH AND1
Top patents by PatentIndex Score
28 records- 0196US10101329B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Oct 16, 2018·9 cites·46 claims
- 0293US9783823B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Oct 10, 2017·14 cites·28 claims
- 0393US9249427B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2012·Granted Feb 2, 2016·24 cites·24 claims
- 0492US9982241B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted May 29, 2018·13 cites·54 claims
- 0591US10688164B2CMV vectors comprising microRNA recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Jun 23, 2020·8 cites·23 claims
- 0691US10532099B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jan 14, 2020·8 cites·67 claims
- 0790US10316334B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jun 11, 2019·4 cites·23 claims
- 0890US9862972B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jan 9, 2018·10 cites·55 claims
- 0990US9541553B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Jan 10, 2017·10 cites·36 claims
- 1087US10760097B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Sep 1, 2020·4 cites·18 claims
- 1185US10428118B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted Oct 1, 2019·5 cites·20 claims
- 1283US10995121B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted May 4, 2021·1 cites·30 claims
- 1381US11091779B2Methods and compositions useful in generating non canonical CD8+ T cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Aug 17, 2021·1 cites·20 claims
- 1476US12442018B2Recombinant cytomegalovirus vectors as vaccines for tuberculosisINT AIDS VACCINE INITITATIVE INC·Filed 2023·Granted Oct 14, 2025·0 cites·15 claims
- 1572US11834669B2Recombinant cytomegalovirus vectors as vaccines for tuberculosisINT AIDS VACCINE INITIATIVE INC·Filed 2021·Granted Dec 5, 2023·0 cites·23 claims
- 1672US11692012B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2021·Granted Jul 4, 2023·0 cites·30 claims
- 1768US11266732B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2018·Granted Mar 8, 2022·0 cites·10 claims
- 1865US2020140888A1Cytomegalovirus vectors enabling control of t cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2019·Application pending·0 cites
- 1962US11305015B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Apr 19, 2022·0 cites·19 claims
- 2062US2013142823A1Cmv glycoproteins and recombinant vectorsSCIENCE UNIVERSITY OREGON HEALTH AND·Filed 2012·Application pending·0 cites
- 2160US2021395771A9CMV Glycoproteins and Recombinant VectorsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2259US11091775B2Recombinant cytomegalovirus vectors as vaccines for tuberculosisAERAS·Filed 2017·Granted Aug 17, 2021·0 cites·28 claims
- 2354US2020368333A1Cmv vectors comprising microrna recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2451US2018298404A1Methods and compositions useful in generating non canonical cd8+ t cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 2550US2022307054A1Modulation of t cell responses by ul18 of human cytomegalovirusUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2650US2022257740A1Tumor-associated antigen-specific t cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2749US2023272036A1Multi-specific t cell receptorsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2841US2004234953A1Japanese macaque herpesvirus nucleic acid and polypeptide sequences and their useUNIV OREGON HEALTH & SCIENCE·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Hansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →